Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 79MR9 | — |
patients have received only the diluent portion of Shingrix; Inappropriate dose of vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 52-year-old male patient who received Herpes zoster (Shingrix) (batch number 79MR9, expiry date 26-AUG-2027) for prophylaxis. On 20-FEB-2026, the patient received Shingrix. On 20-FEB-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patients have received only the diluent portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 10-MAR-2026 The reporter mentioned that patient had received only the diluent portion of Shingrix. This was 1 of 3 cases reported by same reporter.; Sender's Comments: US-GSK-US2026033729:Same reporter/Different patient US-GSK-US2026033731:Same reporter/Different patient